 |
|
|
| |
Map of GDF Countries Updated: March 2008
GDF is ISO 9001:2000 compliant for provision of
quality-assured anti-TB drugs and related services to
eligible national TB control programmes.
|
|
|
 |
 |
|
Welcome to the Global Drug Facility
|
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to facilitate global DOTS expansion or maintenance to support the Stop TB Strategy.
Nominations for GDF Technical Review Committee - Submission deadline May 6, 2009
The Global Drug Facility (GDF) is currently seeking nominations of experts in tuberculosis (TB) control and drug management to join its Technical Review Committee (TRC). The GDF TRC is responsible for reviewing applications to GDF for grants of free anti-TB drugs, and advising the Stop TB Partnership on which grant applications to accept and the level and nature of the grant to provide.
If you or someone you know would be a suitable candidate for the TRC, please submit your nomination to GDF. Candidates for the TRC should have significant expertise and experience in one or more of the following fields: Clinical TB, TB Diagnostics, Drug management, Human Resource Management, International Development, International Financing for anti-TB Drugs, MDR/XDR TB, Paediatric TB, Procurement and Logistics, TB Epidemiology, TB Monitoring and Evaluation and TB/HIV.
Individual nominations should be accompanied by a CV and a cover letter explaining the individual’s interest in and suitability for membership on the TRC. In the case where an institution is nominating a candidate, the nomination should be accompanied by a letter of institutional support for the individual.
All nominations and materials must be sent to the GDF by 6 May 2009 via email to Mr Edin Karahasanovic,karahasanovice@who.int with the subject heading: "NOMINATION FOR GDF TECHNICAL REVIEW COMMITTEE". Queries can be addressed to the same email.
TRC Call for Nominaions
TRC Call for Nominaions (French)
Terms of Reference
Call for the Expressions of Interest for Procurement Agent Services
10 February, 2009
The Global TB Drug Facility (GDF), procurement arm of the Stop TB Partnership Secretariat, housed by the World Health Organization, is seeking a qualified Procurement Agent (PA) to manage the purchase of first-line* anti-Tuberculosis (TB) drugs and related supplies** from an established list of qualified manufacturers for delivery to...
Read more...
Results of the Tender for Desk Auditing Agencies for the Global Drug Facility (RFP Number 4951)
3 September, 2008
The GDF wishes to announce the result of its competitive Request for Proposals RFP Number 4951 designed to select an Agency or Agencies to undertake independent Desk Audit assessments of mission reports from annual visits to GDF grant recipients and/or direct procurement clients.
- In total 5 Responsive Proposals were received and adjudicated: 17 - 18 August
- Proposers were invited to witness the opening of Proposals and recording of financial offers and one Proposer attended.
- The technical scores for the Proposals ranged from: 100 to 380 points (out of maximum of 480 points)
- The financial offers ranged from: US$1693.60 to US$8229
- Two agencies were selected for contract awards on the basis of their technical scores and financial offers: Swiss Center for International Health, Swiss Tropical Institute (SCIH) (Primary awardee: 65% of annual number of audits) and German Leprosy and TB Relief Association (GLRA) (Secondary Awardee: 35% of annual number of audits).
GDF would like to congratulate SCIH and GLRA for their success and thank all Proposers for the efforts they made to prepare their Proposals and participate in this competition.
For further information please contact Maria Patyna at: patynam@who.int
New Long-Term Agreements (LTAs) with first-line TB drug suppliers
19 February, 2008
From September through December 2007 the Global Drug Facility (GDF) conducted a competitive selection process among pre-qualified first-line drug manufacturers through its Procurement Agent, GTZ.
This competitive process is now complete, and GDF and GTZ are pleased to announce that awards have been made to five suppliers. Four of them - Svizera, Cadila, Strides and Lupin - were already serving as GDF suppliers. One new supplier, Macleods, also was selected. This expansion in the supplier pool indicates strong interest and competition among manufacturers, and augurs well for favourable pricing and availability of high quality anti-TB drugs.
GDF is committed to providing affordable high-quality anti-tuberculosis (TB) drugs to countries with a high TB burden and stimulating capacity and competition in the production sector.
|
|
|
